Qoolo

We didn't start Qoolo to build a tool. We started it to make science fit on a small screen.

Then we discovered something bigger.
Nobody had built it yet. So we did.

This is why Qoolo exists.
The format problem.

The life sciences industry doesn't have an engagement problem. It has a format problem. For decades, great science has been packaged into long-format assets: 23-page PDFs, bloated slide decks, 137-page iVAs. All built for a world where doctors had 15 minutes with a rep, or two hours at a desk to read.
That world is gone. The formats stayed.

The gap between how science is delivered and how doctors actually consume it has never been wider. So we got to work. Not to optimize what already exists. But to build what the industry has been missing. Because doctors deserve better access to the science shaping their decisions. And life sciences teams deserve a platform built for how medicine actually moves today.

This is what we're building instead. The medical micro-content category.

Medical micro-content is not shorter PDFs. Not prettier, cleaned-up slides. Not another chatbot with simplified answers and a compliance disclaimer bolted on. It's something fundamentally different.

For doctors, it's scientific knowledge structured for how they actually live and work - on their phones, between patients, in the two minutes they have. Bite-sized. Snackable. Built for the moment.

For life sciences teams, it's a new way to create, review, localize, publish, reuse, and measure compliant content. Qoolo provides the infrastructure - so teams can create fast, speed up MLR review, localize efficiently, publish globally, and reuse compliant content across channels instead of rebuilding it for every market.

This isn't a feature. It isn't an optimization.
It's a new category. We're defining it.

This is what drives us.

Mission

Make medical micro-content a standard part of how life sciences teams communicate. Not as a replacement for everything that exists, but as an essential layer alongside it. Doctors deserve more than one way to access the science that shapes their decisions. And life sciences teams deserve a format built for how medicine moves today. Because great science deserves to travel fast.

Vision

A future where great science actually reaches the people who need it, when they need it. Where a doctor between patients can access the right medical information in two minutes, not two hours. Where life sciences teams don't lose months to formats and friction. Where knowledge moves as medicine does: fast, mobile, without borders. That's the world we're building.

THESE ARE THE PEOPLE BEHIND QOOLO.

Defining a new category requires a rare combination: people who understand the regulatory realities of pharmaceutical organizations deeply enough to know what's broken and the technical ability to build something fundamentally better. That's who we are.

Qoolo leadership

We've sat in the MLR rooms. We've managed the impossible timelines. We've rebuilt the same asset three times for three different markets. We've watched field teams carry materials doctors never reopened. We didn't read about these problems. We lived them.

That's why we built Qoolo.
And that's who's building it.

Alex Stojanovic, PhD, CEO & Chairman of Qoolo

Alex Stojanovic, PhD

Co-Founder
CEO & Chairman

Mika Stojanovic, MBA, Chief Marketing Officer of Qoolo

Mika Stojanovic, MBA

Co-Founder
Chief Marketing Officer

Mladen Prijic, Development Lead of Qoolo

Mladen Prijic

Co-Founder
Development Lead

Advisory board

We don't have advisors for optics. We have people who have operated at the highest levels of pharmaceutical strategy, commercialization, medical academics, and practice who understand exactly why the old model is failing and what needs to change.

Together, our advisors help shape Qoolo’s strategy and ensure our platform delivers meaningful impact across the life sciences industry and medical community.

Medical advisors

John Hwa,
 MD, PhD, FRACP

John Hwa, MD, PhD, FRACP

Professor of Medicine (Cardiology) Yale School of Medicine

Steven J. Evans,
 MD, FACC

Steven J. Evans, MD, FACC

Adjunct Associate Professor of Medicine NYU Grossman School of Medicine

Eric Arehart,
 MD, PhD

Eric Arehart, MD, PhD

Regional Medical Director Specialty Care

Jonathan
 Pirruccello, MD

Jonathan Pirruccello, MD

Medical Oncologist New Hampshire Oncology-Hematology

Sanja Maricic Prijic,
 MD, PhD

Sanja Maricic Prijic, MD, PhD

Anesthesiologist, Assistant Professor of Medicine Clinical Center of Vojvodina University of Novi Sad

Business advisors

Kurt Kessler, PhD

Kurt Kessler, PhD

Former Managing Principal ZS Associates

Sri Madabushi, PhD

Sri Madabushi, PhD

Executive VP, IKS Health Former Co-Founder Google Health

Barb Carlin, MBA

Barb Carlin, MBA

Managing Director Danforth Advisors

Philippe Ghem

Philippe Ghem

CEO, Strate-G Former CCO, Vésale Pharma Former CCO, ASIT biotech

Mathias Hess, MBA

Mathias Hess, MBA

Former SVP, SpringWorks Former SVP, CSL Vifor

The answers you're looking for:

Qoolo is built by a team that comes from inside life sciences, not one that discovered the industry as a market opportunity. Our founding team brings 40+ years of combined experience across life sciences strategy, commercial operations, marketing, and medical communications - on both the client and agency side. Before building Qoolo, our founders worked with 60+ life sciences companies across 4 continents, including organizations in pharma, biotech, medical devices, diagnostics, animal health, and consumer health.

We've sat in the MLR rooms. We've managed the impossible timelines. We've heard from field teams that they never get past the cover slide of the iVA. We didn't read about these problems. We lived them. Qoolo is the platform we wished existed when we were on the other side.

We started with a simple idea: make science fit naturally on a phone screen. Our early attempts focused on layout. Then it became clear the layout was not the problem. The format was. For years, life sciences teams had been packaging important content into the wrong assets, including 137-slide iVAs, 21-page PDFs, and slide decks rebuilt from scratch for every market, all built for a world where doctors had time to sit down and study them. That world is gone. The formats stayed. Content that took months to create became unreadable or too long to scroll when doctors needed it on mobile instead.

We stopped optimizing the old assets and built something new: a platform designed to make compliant medical micro-content easier to create, review, and use in real-world moments. What started as a formatting problem became a new category, and Qoolo is the platform that powers it.

Yes. We built compliance and security into Qoolo from day one, not added later.

On the content side, we manage references and endnotes centrally with PubMed integration, important safety information can be locked into brand themes, and one-click storyboard export generates MLR-ready PDFs structured for workflows such as those managed in Veeva Vault. On the infrastructure side, we use AES 256-bit encryption at rest, TLS 1.2+ in transit, AWS-hosted serverless architecture, logically separated customer data, role-based access controls with audit logging, and annual third-party penetration testing. Our compliance framework aligns with HIPAA, GDPR, and CCPA. Full security information is available on our Security page.

Yes, both.

Larger, established teams use Qoolo to solve the scale problem: managing multiple brands, localizing across markets without rebuilding from scratch, keeping brand control centralized, and producing MLR-ready outputs that fit existing review workflows. Qoolo can also connect into the systems teams already use, so nothing has to change on their end.

Earlier-stage and growing companies use Qoolo to solve a different problem: credibility and capacity. It gives them the content infrastructure to put out compliant, mobile-first, visually credible content. No big design team. No dev resources. No complex tech stack.

The platform is the same either way. Only the starting point differs.

Yes. We use AI in practical ways across the platform to help life sciences teams work faster and more effectively. One example is Qoolo Assistant, an AI-powered guide that detects where you are in the platform and provides structured support. We also use AI for content structuring, localization, PDF-to-micro-content conversion, medical-article-to-micro-content conversion, and other evolving workflows designed to reduce manual work while keeping teams in control. Some of these AI-powered features are genuinely innovative, and several are patent pending.

Our AI is designed to assist, not replace, human judgment. Content still moves through the appropriate review, approval, and compliance processes before use.

Yes. Qoolo is open to connecting with medical doctors and other healthcare professionals around the world who believe in the mission and in the potential of medical micro-content to improve how scientific information is created, shared, and experienced. To explore an advisory relationship, send a LinkedIn profile or CV to medicalteam@qoolo.com, and the Qoolo team will review the background and explore whether there is a fit for collaboration.

Qoolo is a US startup headquartered in Princeton, New Jersey, with R&D team members in Subotica and at the Science and Technology Park in Novi Sad, Serbia.

Yes. Qoolo's founding team has lived and worked in the life sciences industry across the United States, Europe, and Australia. We've also worked with and advised companies across Asia, the Middle East, Africa, and South America. Along the way, we've supported professionals in global roles, regional and multi-country roles, and country-level roles. Our advisor network extends that footprint further.

This international experience helps Qoolo build for the realities of life sciences teams working across regions, markets, and operating models.